ClinicalTrials.Veeva

Menu

Evaluation of the Validity of the Prothrombin Time Internation Normalised Ratio (PT/INR) Measured at the point-of Care on the Arterial Bloodline of Haemodialysis Extracorporeal Blood Flow (COAGHEMO)

R

Regional University Hospital Center (CHRU)

Status

Unknown

Conditions

Haemodialysis

Study type

Observational

Funder types

Other

Identifiers

NCT02902848
COAGHEMO

Details and patient eligibility

About

The purpose of this study is to evaluate the INR value of hemodialyzed patient coagulation state (prothrombin time) measured inside the therapeutical zone and thanks to a portable monitor. The values obtained at the point of care will be compared to the standard biological assessment.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Age > 18
  • Haemodialyzed patient whose INR needs to be monitored
  • Patient not objecting to participate in the study

Trial contacts and locations

1

Loading...

Central trial contact

Yannick Le meur, MD-PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems